GWM
AMPH icon

Gilpin Wealth Management’s Amphastar Pharmaceuticals AMPH Stock Holding History

Gilpin Wealth Management’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$162 Buy
8
+3
+60% +$61 ﹤0.01% 958
2026
Q1 		$98 Buy
5
+3
+150% +$73 ﹤0.01% 952
2025
Q4 		$54 Buy
+2
New +$52 ﹤0.01% 941

Other funds holding AMPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Gilpin Wealth Management's AMPH Position: Q2 2026 in Review

Gilpin Wealth Management increased its Amphastar Pharmaceuticals (AMPH) stake by 60% in Q2 2026, buying an estimated $61 and bringing the position to 8 shares worth $162. The position accounts for ﹤0.01% of the portfolio, ranked #958.

Gilpin Wealth Management first reported a position in AMPH in Q4 2025 and has held it in 3 quarters since. 210 funds tracked by Wall St. Rank hold AMPH as of Q2 2026.

  • Gilpin Wealth Management held 8 shares of Amphastar Pharmaceuticals worth $162 as of Q2 2026.
  • Gilpin Wealth Management bought 3 Amphastar Pharmaceuticals shares in Q2 2026, an estimated $61.
  • Amphastar Pharmaceuticals made up ﹤0.01% of Gilpin Wealth Management's portfolio in Q2 2026, its #958 holding.
  • Gilpin Wealth Management first reported a position in Amphastar Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • 210 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q2 2026.

Based on Gilpin Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.